๐ข Recruiting
Phase 1
๐ Investigational Drug / Biologic
NCT04227847
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
๐ University of Alabama at Birmingham โ Birmingham, Alabama
View Study & Checklist โ